In its report titled “AI-N’t Gonna Fix This Mess,” Kerrisdale Capital expresseds doubt regarding an AI-fueled turnaround for Lumen. Lumen’s stock is up more than 200% over the past month ...

Hedge fund Kerrisdale Capital, which is well-known for its short selling, took the other side of the trade and disclosed two new long positions on Wednesday. Kerrisdale has generally been bearish ...

In a recently published report, Kerrisdale Capital says it is short shares of Oklo (OKLO), "a $3B nuclear energy company that went public via SPAC six months ago — with no regulator-approved ...

Kerrisdale Capital told Benzinga on Monday that the firm is still short Altimmune stock. Altimmune is expected to report fourth-quarter financial results in early March, although a date has not ...

Kerrisdale Capital on Tuesday disclosed a short position in Lumen Technologies and raised doubts on its focus on artificial intelligence to fuel a turnaround in the company's telecommunications ...

Sahm Adrangi’s Kerrisdale Capital has doubled down on its position in Luxoft, which is now 20% of the firm’s portfolio. Adrangi shared his thesis exclusively with ValueWalk and explained in an ...

Kerrisdale should have included these metrics in its analysis to construct a complete picture in my opinion and to avoid the impression of cherry picking. I have covered this in an earlier paragraph.

Last year was a tough one for hedge funds. A majority of funds lost money, according to Hedge Fund Intelligence. More hedge funds lost money than did in 2008. But Kerrisdale Capital apparently had ...

Is the rally over for Carvana (NYSE:CVNA) stock? According to an expert short seller, the meme stock isn’t just overhyped but “insolvent” and “poorly run.” Kerrisdale Capital has issued ...